Sponsor or institution

Clinical trials and research at DualityBio Inc.

• 8Clinical trials
• 6Countries

Newest trials

All recruiting trials (8)

• DB-1324 in advanced gastrointestinal tumors

  This study tests a new drug, DB-1324, in people with advanced or metastatic gastrointestinal cancers to see if it is safe and tolerable and to get an early sense of its activity against tumors.

  Recruiting at 9 sites Phase 1/2 DualityBio Inc. · Port Saint Lucie, Florida and 8 other locations · NCT07263594

• DB-1317 for selected advanced or metastatic solid tumors

  This study will try DB-1317, given every three weeks, in adults with advanced or metastatic solid tumors that have progressed after standard treatments.

  Recruiting at 14 sites Phase 1 DualityBio Inc. · Los Angeles, California and 13 other locations · NCT07141706

• DB-1311 plus BNT327 or DB-1305 for advanced solid tumors

  This trial tests whether combining the experimental drug DB-1311 with BNT327 or with DB-1305 can help adults with advanced or metastatic solid tumors such as HCC, cervical cancer, melanoma, head and neck cancer, platinum-resistant ovarian cancer, or non-small cell lung cancer.

  Recruiting at 37 sites Phase 2 DualityBio Inc. · Los Angeles, California and 36 other locations · NCT06953089

• Testing DB-2304 in healthy adults and patients with lupus

  This study is testing a new drug called DB-2304 in healthy adults and people with lupus to see how safe it is and how it works in the body.

  Recruiting at 5 sites Phase 1/2 DualityBio Inc. · La Palma, California and 6 other locations · NCT06625671

• Testing DB-1419 for advanced solid tumors

  This study is testing a new drug called DB-1419 to see if it can help adults with advanced solid tumors that can't be surgically removed and haven't responded to other treatments.

  Recruiting at 21 sites Phase 1/2 DualityBio Inc. · Los Angeles, California and 35 other locations · NCT06554795

• Evaluating DB-1311/BNT324 for advanced solid tumors

  This study is testing a new treatment called DB-1311/BNT324 to see if it is safe and effective for people with advanced solid tumors.

  Recruiting at 107 sites Phase 1/2 DualityBio Inc. · Tucson, Arizona and 106 other locations · NCT05914116

• Evaluating DB-1310 for advanced solid tumors

  This study is testing a new treatment called DB-1310 to see if it is safe and effective for people with advanced solid tumors.

  Recruiting at 21 sites Phase 1/2 DualityBio Inc. · Sacramento, California and 23 other locations · NCT05785741

• Evaluating DB-1303/BNT323 for HER2-positive advanced solid tumors

  This study is testing a new treatment called DB-1303/BNT323 to see if it is safe and effective for people with advanced solid tumors that have high levels of HER2.

  Recruiting at 46 sites Phase 1/2 DualityBio Inc. · Cerritos, California and 101 other locations · NCT05150691

Quick answers

How many clinical trials run by DualityBio Inc. are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in United States (8 trials), Australia (7 trials), China (7 trials), Taiwan (3 trials), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 6, Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →